Cargando…

Assessment of the Effects of Zoledronic Acid Therapy on Bone Metabolic Indicators in Hormone-Resistant Prostate Cancer Patients with Bone Metastatasis

Purpose. Assessment of effects of zoledronic acid therapy on bone metabolic indicators in hormone-resistant prostate cancer patients with bone metastasis. Material and Methods. Hormone-resistant prostate cancer patients who were identified to have metastases in their bone scintigraphy were taken to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Demirtas, Abdullah, Sahin, Nurettin, Caniklioglu, Mehmet, Kula, Mustafa, Ekmekcioglu, Oguz, Tatlisen, Atila
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scholarly Research Network 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195994/ https://www.ncbi.nlm.nih.gov/pubmed/22084798 http://dx.doi.org/10.5402/2011/392014

Ejemplares similares

Small Cell Prostate Carcinoma: A Case Report and Review of the Literature
por: Demirtaş, Abdullah, et al.
Publicado: (2013)

Primary Obstructive Megaureter with Giant Ureteral Stone: A Case Report
por: Demirtaş, Abdullah, et al.
Publicado: (2013)

The Treatment of Recurrent Urothelial Tumors of the Upper Urinary System and at Urostomy Site following Radical Cystectomy with Intraureteral Bacillus Calmette-Guérin and Cryotherapy
por: Demirtaş, Abdullah, et al.
Publicado: (2013)

Can Neutrophil-Lymphocyte Ratio and Lymph Node Density Be Used as Prognostic Factors in Patients Undergoing Radical Cystectomy?
por: Demirtaş, Abdullah, et al.
Publicado: (2013)

Assessment of the Effects of Access Count in Percutaneous Nephrolithotomy on Renal Functions by Technetium-99m-Dimercaptosuccinic Acid Scintigraphy
por: Demirtaş, Abdullah, et al.
Publicado: (2013)

Economic Evaluation of Denosumab Compared with Zoledronic Acid in Hormone-Refractory Prostate Cancer Patients with Bone Metastases
por: Rader, Michael, et al.
Publicado: (2012)

Economic Evaluation of Denosumab Compared with Zoledronic Acid in Hormone-Refractory Prostate Cancer Patients with Bone Metastases
por: Xie, Jipan, et al.
Publicado: (2011)

Combined use of zoledronic acid and 153Sm-EDTMP in hormone-refractory prostate cancer patients with bone metastases
por: Lam, Marnix G. E. H., et al.
Publicado: (2007)

Effect of Zoledronic Acid on Bone Mineral Density in Men with Prostate Cancer Receiving Gonadotropin-Releasing Hormone Analog
por: Kapoor, Anoop, et al.
Publicado: (2011)

The ZOTECT study: Effect of zoledronic acid on bone metabolism in patients with bone metastases from prostate or breast cancer
por: Hadji, Peyman, et al.
Publicado: (2012)

Low-dose zoledronate for the treatment of bone metastasis secondary to prostate cancer
por: Akoury, Elie, et al.
Publicado: (2019)

The effect of zoledronate during bone healing
por: Matos, Marcos Almeida, et al.
Publicado: (2010)

Ten cases with 46,XX testicular disorder of sex development: single center experience
por: Akinsal, Emre Can, et al.
Publicado: (2017)

Administration of zoledronic acid enhances the effects of docetaxel on growth of prostate cancer in the bone environment
por: Brubaker, Kristen D, et al.
Publicado: (2006)

Zoledronic acid in the management of metastatic bone disease
por: Polascik, Thomas J, et al.
Publicado: (2008)

Time associated with intravenous zoledronic acid administration in patients with breast or prostate cancer and bone metastasis
por: Richhariya, Akshara, et al.
Publicado: (2012)

Humanized bone facilitates prostate cancer metastasis and recapitulates therapeutic effects of zoledronic acid in vivo
por: Landgraf, Marietta, et al.
Publicado: (2019)

Cryoablation combined with zoledronic acid in comparison with cryoablation and zoledronic acid alone in the treatment of painful bone metastases
por: LI, FENQIANG, et al.
Publicado: (2014)

Zoledronic Acid Preserves Bone Structure and Increases Survival but Does Not Limit Tumour Incidence in a Prostate Cancer Bone Metastasis Model
por: Hung, Tzong-Tyng, et al.
Publicado: (2011)

Correction: Humanized bone facilitates prostate cancer metastasis and recapitulates therapeutic effects of Zoledronic acid in vivo
por: Landgraf, Marietta, et al.
Publicado: (2020)

Zoledronic acid sequential to teriparatide may promote greater inhibition of bone resorption than zoledronic acid alone
por: Giveon, Sharon, et al.
Publicado: (2023)

Bone structure and remodelling in stroke patients: Early effects of zoledronate()
por: Poole, Kenneth E.S., et al.
Publicado: (2009)

Controlled Delivery of Zoledronate Improved Bone Formation Locally In Vivo
por: Gou, Wenlong, et al.
Publicado: (2014)

The impact of body mass index on reproductive hormones, testosterone/estradiol ratio and semen parameters
por: Oztekin, Unal, et al.
Publicado: (2020)

Effects of Zoledronic Acid on Physiologic Bone Remodeling of Condylar Part of TMJ: A Radiologic and Histomorphometric Examination in Rabbits
por: Tatli, Ufuk, et al.
Publicado: (2014)

Zoledronic acid prevents decreases in bone mineral density in patients with prostate cancer undergoing combined androgen blockade
por: Nishizawa, Satoshi, et al.
Publicado: (2014)

Duration of suppression of bone turnover following treatment with zoledronic acid in men with metastatic castration-resistant prostate cancer
por: Niraula, Saroj, et al.
Publicado: (2017)

Comparison of Infection and Urosepsis Rates of Ciprofloxacin and Ceftriaxone Prophylaxis before Percutaneous Nephrolithotomy: A Prospective and Randomised Study
por: Demirtas, Abdullah, et al.
Publicado: (2012)

Bone-seeking nanoplatform co-delivering cisplatin and zoledronate for synergistic therapy of breast cancer bone metastasis and bone resorption
por: Huang, Yanjuan, et al.
Publicado: (2020)

Protection of bone in premenopausal women with breast cancer: focus on zoledronic acid
por: Aft, Rebecca
Publicado: (2012)

Zoledronic acid for prevention of bone loss in patients receiving bariatric surgery
por: Liu, Yi, et al.
Publicado: (2021)

Insufficient Mitigation of Bone Loss by Zoledronic Acid after Treatment with Denosumab
por: Park, Jung-Wee
Publicado: (2021)

Effect of Acetazolamide and Zoledronate on Simulated High Altitude-Induced Bone Loss
por: Brent, Mikkel Bo, et al.
Publicado: (2022)

Zoledronate combined metal-organic frameworks for bone-targeting and drugs deliveries
por: Pan, Yixiao, et al.
Publicado: (2022)

Zoledronic Acid Implant Coating Results in Local Medullary Bone Growth
por: Quarterman, Juliana C., et al.
Publicado: (2022)

Dietary nitrate improves jaw bone remodelling in zoledronate‐treated mice
por: Pan, Wen, et al.
Publicado: (2023)

Local treatment of a bone graft by soaking in zoledronic acid inhibits bone resorption and bone formation. A bone chamber study in rats
por: Belfrage, Ola, et al.
Publicado: (2012)

Differential effect of zoledronic acid on normal trabecular and cortical bone density in oncologic patients with bone metastases
por: Quattrocchi, Carlo C., et al.
Publicado: (2012)

Zoledronic Acid Ameliorates the Bone Turnover Activity and Periprosthetic Bone Preservation in Cementless Total Hip Arthroplasty
por: Hsu, Allen Herng Shouh, et al.
Publicado: (2022)

Determining Bone Bruises of the Knee with Magnetic Resonance Imaging
por: Uçar, Bekir Yavuz, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_u5lj705n8c6g543gv6eugkoen3